Drägerwerk AG & Co. KGaA (0MT8.L)

EUR 50.0

(0.0%)

EBITDA Summary of Drägerwerk AG & Co. KGaA

  • Drägerwerk AG & Co. KGaA's latest annual EBITDA in 2023 was 318.33 Million EUR , up 565.4% from previous year.
  • Drägerwerk AG & Co. KGaA's latest quarterly EBITDA in 2024 Q2 was 49.9 Million EUR , up 51.59% from previous quarter.
  • Drägerwerk AG & Co. KGaA reported an annual EBITDA of 62.62 Million EUR in 2022, down -126.06% from previous year.
  • Drägerwerk AG & Co. KGaA reported an annual EBITDA of 422.65 Million EUR in 2021, down -31.75% from previous year.
  • Drägerwerk AG & Co. KGaA reported a quarterly EBITDA of 48.32 Million EUR for 2024 Q1, down -64.79% from previous quarter.
  • Drägerwerk AG & Co. KGaA reported a quarterly EBITDA of 147.4 Million EUR for 2023 Q4, up 363.43% from previous quarter.

Annual EBITDA Chart of Drägerwerk AG & Co. KGaA (2023 - 2005)

Historical Annual EBITDA of Drägerwerk AG & Co. KGaA (2023 - 2005)

Year EBITDA EBITDA Growth
2023 318.33 Million EUR 565.4%
2022 62.62 Million EUR -126.06%
2021 422.65 Million EUR -31.75%
2020 520.22 Million EUR 388.33%
2019 190.79 Million EUR 25.74%
2018 145.96 Million EUR -56.11%
2017 237.84 Million EUR -4.77%
2016 220.9 Million EUR 101.72%
2015 79.49 Million EUR -57.97%
2014 189.16 Million EUR -8.69%
2013 207.18 Million EUR -13.25%
2012 238.82 Million EUR 11.72%
2011 217.61 Million EUR 10.89%
2010 192.78 Million EUR 37.3%
2009 140.4 Million EUR -12.33%
2008 160.35 Million EUR -6.23%
2007 171.21 Million EUR -9.05%
2006 190.93 Million EUR -87.01%
2005 164.76 Million EUR 0.0%

Peer EBITDA Comparison of Drägerwerk AG & Co. KGaA

Name EBITDA EBITDA Difference
Cegedim SA 95.25 Million EUR -234.205%
Guerbet SA 90.09 Million EUR -253.335%
Nexus AG 53.43 Million EUR -495.785%
Bastide Le Confort Médical SA 110.32 Million EUR -188.545%
Revenio Group Oyj 30.09 Million EUR -957.94%
Sartorius Aktiengesellschaft 811.2 Million EUR 60.758%
LNA Santé SA 144.63 Million EUR -120.095%
Siemens Healthineers AG 4.22 Billion EUR 92.465%
Medios AG 52.81 Million EUR -502.723%
Equasens Société anonyme 71.29 Million EUR -346.478%
Stratec SE 39.82 Million EUR -699.412%